FVvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with FV, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FV performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/15/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FV ETF 2 | +3.70%– | +4.28%– | +18.25%– | +20.23%– | +68.63%– | +60.69%– |
| Flows | FV ETF 2 | +$11M– | +$12M– | -$335M– | -$436M– | -$956M– | -$419M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FV ETF 2 | +15.39%– | +18.08%– | +19.59%– | +20.92%– |
| Max drawdown | FV ETF 2 | -4.01%– | -13.46%– | -22.88%– | -22.88%– |
| Max drawdown duration | FV ETF 2 | 25d– | 96d– | 248d– | 248d– |
Trading data
FV | ETF 2 | |
Last sale 10/16/2026 at 1:30 PM | $73.16 | – |
| Previous close 10/15/2026 | $74.32 | – |
| Consolidated volume 10/15/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
FV | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/16/2026 at 1:30 PM
Live
Closed
FV | ETF 2 | |
|---|---|---|
| Last price | $73.16 | – |
| 1D performance | -1.56% | – |
| AuM | $3.87 B | – |
| E/R | 0.89% | – |
Characteristics
FV | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | First Trust | – |
| Benchmark | Dorsey Wright Focus Five Index | – |
| N° of holdings | 230 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | March 5, 2014 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
FV
USA
91.45%
Other
8.55%
ETF 2
Sectors
FV
Healthcare
41.82%
Technology
33.57%
Industrials
13.92%
Other
10.7%
ETF 2
Advertisement
Diversification
FV
Total weight of top 15 holdings out of 15
21.79%
ETF 2
–
Top 15 holdings
Data as of August 31, 2026
FV
Merck & Co., Inc.
1.60%
Union Pacific Corp.
1.58%
General Motors Co.
1.56%
Amgen, Inc.
1.53%
Regeneron Pharmaceuticals, Inc.
1.50%
AbbVie, Inc.
1.48%
Vertex Pharmaceuticals, Inc.
1.46%
Eli Lilly & Co.
1.45%
Biogen, Inc.
1.45%
Johnson & Johnson
1.44%
Bristol Myers Squibb Co.
1.41%
Ford Motor Co.
1.41%
Gilead Sciences, Inc.
1.41%
Tesla, Inc.
1.27%
Halozyme Therapeutics, Inc.
1.24%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
